billHR9864Event Wednesday, July 22, 2026Analyzed

Reducing Military Health Care Wait Times Act

Neutral

Summary

HR 9864, the Reducing Military Health Care Wait Times Act, is an early-stage bill that would require the Department of Defense to publish TRICARE appointment wait times and referral data on its website. It authorizes no funding and is in the earliest legislative stage, having been referred to committee with no cosponsors. No direct market impact is expected.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR 9864 is a transparency bill with no funding, no contracts, and no direct revenue impact on any public company.
  • 2.The bill codifies existing voluntary DoD reporting—no new data collection or spending is required.
  • 3.Zero cosponsors and early committee referral indicate low legislative momentum; passage is uncertain.

Market Implications

No market implications. The bill does not affect any public company's revenue, costs, or competitive position. TRICARE is administered by the Defense Health Agency, not by private contractors. Healthcare and defense tickers ($UNH, $LMT, $BAH, $LDOS) are unaffected.

Full Analysis

On July 22, 2026, Rep. Neguse introduced HR 9864, which would amend 10 U.S.C. 1073b to require the Secretary of Defense to include on a DoD website the average days between booking and appointment at military medical treatment facilities, and the percentage of referrals made within one business day. The bill is in the earliest legislative stage: referred to the House Armed Services Committee with zero cosponsors. It authorizes no funding—it is a transparency mandate, not a spending bill. The money trail is absent: no contracts, no appropriations, no tax credits. The bill's mechanism is a reporting requirement on the Defense Health Agency, which already voluntarily includes this data in its annual TRICARE Program Evaluation Report. The bill would codify existing practice. No convergence exists with the provided presidential proclamation on chemical manufacturing regulatory relief, which addresses a different policy domain. Structural winners and losers: none. The bill does not change procurement, reimbursement rates, or patient volumes at military treatment facilities. Timeline: the bill must pass the House Armed Services Committee, the full House, the Senate, and be signed by The President. Given no cosponsors and early stage, passage in the 119th Congress is uncertain and likely low priority.

Key Legislators

Rep. Neguse, Joe [D-CO-2]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 20, 2026

Further Strengthening Actions Taken to Adjust Imports of Aluminum into the United States

This proclamation modifies the Section 232 tariff regime on aluminum imports by authorizing the Secretary of Commerce to establish a program that incentivizes new U.S. investment in primary aluminum production. Companies with approved onshoring plans can import primary aluminum at half the standard Section 232 duty rate, up to the anticipated annual output of their new or expanded facilities, with construction required to start by January 20, 2029. The action aims to boost domestic primary aluminum supply for national security and defense industrial base needs.

Exec OrderJul 20, 2026

Securing America’s Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials

This executive order restricts waivers for foreign-sourced critical materials in defense contracts, effective January 1, 2027, and mandates that defense contractors map their supply chains from raw materials to end products, vet subcontractors for risks, and prohibit covered materials from unreliable foreign suppliers. It directs the Secretary of War to enforce strict compliance, including requiring mitigation plans for any non-compliant materials and establishing penalties for fraud or willful noncompliance.

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →